ARTICLE | Company News
Ionis Pharmaceuticals, Dynacure deal
October 31, 2016 7:00 AM UTC
Ionis and newco Dynacure partnered to use Ionis’ antisense platform to discover a treatment for rare centronuclear myopathies targeting dynamin 2 (DNM2). Dynacure was spun out of the Institute of Gene...